All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
Adopting the final Annual Report
PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding election of board members and the number of board members.
PostNews

BioStock: PHI’s new CEO: “I am excited to lead us forward with new energy”
Anders Månsson was recently appointed CEO of Phase Holographic Imaging. With extensive leadership experience in the international life sciences sector, he aims to expand PHI’s global reach and position the company as a leader in non-invasive cell quality control technologies. BioStock spoke with him about his vision for the future.
PostNews: Press Release
Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ)
Phase Holographic Imaging PHI AB (publ) held its annual general meeting on 31 October 2024. The following resolutions were made.
PostNews: Press Release
PHI secures a loan from Altium SA
Phase Holographic Imaging PHI AB (“PHI”) announces that the Company has been provided a loan of SEK 7 million from the main shareholder Altium SA. PHI and Altium SA are also in dialogues regarding long-term financing of PHI.
PostNews: Press Release
PHI AB’s warrant exercise registered at the Swedish Companies Registration Office
Phase Holographic Imaging PHI AB (“PHI” or “Company”) today announces that the new shares from the exercise of warrants of series TO 4 have been registered at the Swedish Companies Registration Office.
PostNews: Press Release
PHI appoints Anders Månsson as new CEO
The board of Phase Holographic Imaging (PHI) has today appointed Anders Månsson as the new CEO of PHI as of November 1, 2024. The current CEO, Patrik Eschricht, will remain in his role until November 1, 2024, and ensure a smooth handover to Anders Månsson.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.

BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.

BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

BioStock: PHI’s CEO reflects on global roadshow success
BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.

BioStock: PHI on how TO 3 proceeds will be used
BioStock talked to CEO Patrik Eschricht to learn how the TO 3 proceeds would be used.